Learning outcomes
By the end of this lesson you should be able to: describe the pathophysiology of a pulmonary embolus and relate it to Virchow's triad; calculate a Wells or Geneva pre-test probability for a suspected embolus; apply the diagnostic algorithm, including the correct use and misuse of the D-dimer; recognise the clinical features of a high-risk embolus with right heart strain; state the immediate anticoagulation and reperfusion decisions; and define pulmonary hypertension and outline its causes and treatment.
Prerequisites
PHYS 101 (the pulmonary circulation, right ventricular function and gas exchange), MED 301 lesson 5 (the ECG, including right heart strain), lesson 4 (sepsis) and lesson 3 (shunt physiology), and PHRM 202 (anticoagulants and thrombolytics).
The big idea
The embolus does two things, and the clinical picture is the sum of both. It occludes a pulmonary artery branch, which deprives a segment of the lung of blood flow: that segment is now ventilated but not perfused, which is alveolar dead space, so carbon dioxide rises and hypoxaemia follows because blood is redistributed to alveoli that were already poorly ventilated. More importantly, it obstructs the outflow of the right ventricle, which must generate a pressure it was not built to withstand; that ventricle fails, its filling pressure rises, the septum shifts, and the cardiac output falls. The patient who dies of a pulmonary embolus dies of right ventricular failure, not of hypoxaemia.
NoteThe most common electrocardiographic finding in pulmonary embolism is sinus tachycardia. The classic S1Q3T3 pattern — an S wave in lead I, a Q wave in lead III and an inverted T wave in lead III — with right axis deviation, a right bundle branch block or T wave inversion in V1 to V4 indicates right heart strain and points to the size of the clot rather than to the diagnosis.
Virchow's triad: where the thrombus forms
| Limb of the triad | Mechanism | Clinical examples |
|---|---|---|
| Stasis of blood flow | Flow in the valve pockets of the calf veins slows, so activated clotting factors accumulate locally rather than being diluted | Immobility, long-haul travel, long operations, casts and splints, obesity, pregnancy, paralysis, heart failure |
| Injury to the vessel wall | Damaged endothelium activates coagulation and provides a surface for platelet adhesion | Trauma, surgery (particularly orthopaedic and pelvic), central venous catheters, previous deep vein thrombosis |
| Hypercoagulability of the blood | A constitutional or acquired tendency so that clot forms more readily | Malignancy, pregnancy and the puerperium, oestrogen therapy, antiphospholipid syndrome, inflammatory disease, nephrotic syndrome, thrombophilia, dehydration, smoking |
Nearly three quarters of patients with a pulmonary embolus have a demonstrable deep vein thrombosis, and the majority of patients with a proximal deep vein thrombosis have an asymptomatic embolus. The two are one disease, so a patient with a swollen, tender calf and breathlessness has both, and a patient with a pulmonary embolus needs their legs examined and imaged.
The clinical presentation and the pre-test probability
| Finding | |
|---|---|
| Symptoms | Sudden pleuritic chest pain, breathlessness, haemoptysis (from a pulmonary infarct), cough, syncope or a sense of impending collapse, and anxiety |
| Signs | Tachypnoea, tachycardia, a raised jugular venous pressure, a loud pulmonary component of the second heart sound, a low-grade fever, calf swelling or tenderness, and in the extreme a collapse with a raised venous pressure and a low arterial pressure |
| Effects that look like something else | A patient with pleuritic pain after surgery, a patient with breathlessness after a flight, a postoperative patient who desaturates, and a breathless patient with a clear chest radiograph |
| Wells score item | Points |
|---|---|
| Clinical signs of deep vein thrombosis (swelling, tenderness) | 3 |
| Pulmonary embolism is the most likely diagnosis, or an alternative is unlikely | 3 |
| Previous deep vein thrombosis or pulmonary embolism | 1.5 |
| Heart rate above 100 | 1.5 |
| Immobilisation for at least 3 days, or surgery within 4 weeks | 1.5 |
| Active cancer | 1 |
| Haemoptysis | 1 |
A two-level version of the same score is what most protocols use: a score of 4 or less makes the embolism unlikely, and a score above 4 makes it likely. That binary divides the pathway — the unlikely arm goes to a D-dimer, and the likely arm goes straight to definitive imaging, because in that group a negative D-dimer would not be safe enough to act on.
D-dimer: what it can and cannot do
D-dimer is a fibrin degradation product, and it is raised whenever there is clot formation and breakdown somewhere in the body. It is therefore sensitive but entirely non-specific: it is raised in infection, malignancy, pregnancy, the postoperative state, trauma, aneurysmal disease and old age. Its value is a negative result in a patient whose pre-test probability is low, where it can safely exclude the diagnosis. A positive D-dimer never diagnoses anything, and a negative D-dimer in a patient in whom the embolism is likely does not mean it is absent.
| Use | Rule | Reason |
|---|---|---|
| Excluding the diagnosis | Only when the pre-test probability is low or the score makes the embolism unlikely | The sensitivity in that setting is high enough that a negative result reduces the post-test probability below the threshold for investigation |
| Age adjustment | In patients over 50, the threshold is age multiplied by 10 nanograms per millilitre (for example 700 in a 70-year-old) | Age alone raises the D-dimer, so an unadjusted threshold generates many unnecessary scans in the elderly |
| Diagnosing the diagnosis | Never: a positive result is followed by imaging | The test is raised in a third of all medical inpatients without any thrombotic disease |
| When the probability is high | Do not order it: go to imaging and treat while waiting | The post-test probability after a negative D-dimer in a high-probability patient is still too high to act on |
Watch outThe single commonest error in the pathway is ordering a D-dimer in a patient in whom the embolism is clinically likely and then standing down when it returns negative. The test was never capable of answering the question in that patient.
The diagnostic pathway
| Probability | Next step | If positive | If negative |
|---|---|---|---|
| Unlikely (Wells 4 or less) | D-dimer | CT pulmonary angiography | No further investigation; consider another diagnosis and repeat if symptoms persist |
| Likely (Wells above 4) | Immediate CT pulmonary angiography; start therapeutic anticoagulation while awaiting it if the delay is anticipated | Treat and assess the risk of the clot | Consider an alternative diagnosis and further imaging, including a bilateral leg ultrasound or ventilation-perfusion scan |
| Unstable or peri-arrest | Bedside echocardiography looking for right ventricular dilatation and dysfunction, with immediate reperfusion if positive | High-risk embolism: thrombolysis | Continue resuscitation and address the reversible causes |
| Pregnancy or renal impairment or contrast contraindication | Bilateral leg compression ultrasound first, and a ventilation-perfusion scan or perfusion-only scanning if the legs are clear | Treat | Consider CTPA with fetal risk assessment or a normogram-guided pathway |
Ventilation-perfusion scanning remains useful where iodinated contrast is contraindicated — renal impairment, pregnancy, severe allergy — because the isotope scan shows a ventilated but unperfused segment. The trade-off is that a normal chest radiograph is required for the result to be interpretable, and a third of scans are non-diagnostic.
Risk stratification and treatment
| Risk | Haemodynamics | Right ventricle | Treatment |
|---|---|---|---|
| High risk (massive) | Hypotension — a systolic below 90 millimetres of mercury for 15 minutes or more, or a fall of 40 or more, or cardiac arrest, or shock requiring inotropes | Dilated and hypokinetic on echo or CT | Systemic thrombolysis (alteplase) unless absolutely contraindicated; percutaneous catheter-directed therapy or surgical embolectomy when lysis fails or is contraindicated |
| Intermediate high risk | Normotensive, but with right ventricular dysfunction on imaging and a raised troponin or natriuretic peptide | Dilated and/or hypokinetic, with biomarkers positive | Therapeutic anticoagulation and monitored admission; thrombolysis for rescue if the patient deteriorates |
| Intermediate low risk | Normotensive with right ventricular dysfunction or biomarkers alone | One positive, one negative | Therapeutic anticoagulation, usually on a ward with early mobilisation |
| Low risk | Normotensive with no right ventricular dysfunction and negative biomarkers | Normal | Outpatient management may be appropriate with a direct oral anticoagulant and a structured follow-up, in a patient without another reason for admission |
Anticoagulation is the therapy in every case, because it stops propagation and recurrence while the body lyses what is already there. The usual course is an initial parenteral agent — low molecular weight heparin or fondaparinux — followed by a direct oral anticoagulant (apixaban or rivaroxaban) for at least three months; then a decision on extended therapy driven by whether the embolus was provoked, and by the bleeding risk. Warfarin is used where a direct oral anticoagulant is contraindicated, and it is overlapped with heparin until the international normalised ratio is therapeutic.
Watch outAn inferior vena cava filter is not an alternative to anticoagulation: its only accepted role is in a patient with an acute proximal deep vein thrombosis or pulmonary embolism in whom anticoagulation is absolutely contraindicated, or in whom it fails. Once anticoagulation becomes possible, the filter is removed or the anticoagulant is restarted.
| Contraindication to thrombolysis | Note |
|---|---|
| Absolute (roughly) | Any prior intracranial haemorrhage, a known intracranial neoplasm, an ischaemic stroke within three months, a suspected aortic dissection, active bleeding or a bleeding diathesis, recent significant head or facial trauma, recent intracranial or spinal surgery |
| Relative | Current anticoagulation with controlled levels, a transient ischaemic attack within six months, uncontrolled hypertension above 180/110, pregnancy, recent internal bleeding, a recent major operation or prolonged cardiopulmonary resuscitation |
Pulmonary hypertension
| Group | Mechanism | Examples |
|---|---|---|
| 1 — Pulmonary arterial hypertension | Remodelling of the small pulmonary arterioles with a raised resistance | Idiopathic, heritable, connective tissue disease (scleroderma), HIV, portal hypertension, congenital shunts, drug-induced (anorexigens, methamphetamine) |
| 2 — Left heart disease | A raised left atrial and pulmonary venous pressure transmitted backwards | Heart failure with reduced or preserved ejection fraction, valve disease |
| 3 — Lung disease and hypoxia | Chronic hypoxia causes vasoconstriction and remodelling | Chronic obstructive pulmonary disease, interstitial lung disease, obstructive sleep apnoea, high altitude |
| 4 — Chronic thromboembolic | Organised, fibrotic emboli that fail to resolve | Proximal disease after a pulmonary embolism, which is potentially curable by surgery |
| 5 — Unclear and multifactorial | Haematological, systemic and metabolic mechanisms | Chronic haemolytic anaemia, sarcoid, chronic renal failure |
The presentation is the same whichever the group: exertional breathlessness, fatigue, chest pain, syncope, and a raised jugular venous pressure with a loud pulmonary second sound and a left parasternal heave, with a low cardiac output in the late stage. The management is to treat the underlying cause — anticoagulation and surgical endarterectomy for the chronic thromboembolic group, oxygen and treatment of lung disease for group 3, and optimisation of the left heart for group 2 — with specific vasodilator therapy (an endothelin receptor antagonist, a phosphodiesterase 5 inhibitor, a soluble guanylate cyclase stimulant, or a prostacyclin analogue) reserved for the specialist management of pulmonary arterial hypertension.
Watch outNever give a non-selective vasodilator or a calcium channel blocker to a patient with pulmonary hypertension from left heart disease or lung disease, and never treat pulmonary hypertension from chronic lung disease with oxygen as though it were a primary vascular disease. The right heart needs its preload and its oxygenation, not a vasodilator.
Common mistakes
Watch outOrdering a D-dimer in a high-probability patient and taking a negative result as exclusion. In that setting the correct action is imaging, with anticoagulation started if the imaging will be delayed.
Watch outWithholding anticoagulation while waiting for the CT pulmonary angiogram in a patient with a likely pulmonary embolism. The risk of death in the hours before the scan exceeds the risk of bleeding in a patient without a contraindication, so the drug is given and the scan follows.
Watch outDeferring treatment in a normotensive patient with an intermediate-risk embolism and right ventricular dysfunction. These patients can deteriorate abruptly, so they are monitored and the rescue thrombolysis decision is planned rather than improvised.
Watch outAttributing pleuritic chest pain to a musculoskeletal cause in a patient who has had recent surgery, is pregnant, has cancer, or has a swollen calf. The pre-test probability is set by the context, and the context in those patients is high.
Check your understanding
Why does a patient with a large pulmonary embolus collapse rather than simply become breathless?
In which patients is a D-dimer useful for excluding a pulmonary embolism, and in which is it actively unsafe to rely on?
A patient with a confirmed submassive pulmonary embolism has a raised troponin and a dilated right ventricle on CT. How does that change the management?
Multiple choice
A patient has pleuritic chest pain, a heart rate of 112 and a haematemesis-free Wells score of 5, making a pulmonary embolism likely. What is the correct next step?
Which patient is most appropriate for D-dimer testing to exclude pulmonary embolism?
A patient with a pulmonary embolism is hypotensive, with a systolic blood pressure of 80 and signs of right heart strain on the bedside echocardiogram. Which treatment is indicated?
Which of the following is NOT one of the limbs of Virchow's triad?
A patient with an obstructive sleep apnoea and a chronically raised carbon dioxide tension has exertional breathlessness, a raised jugular venous pressure and echo evidence of pulmonary hypertension. Which mechanism is most likely?
Module summary and next
Pulmonary embolism is a disease of the deep veins and the pulmonary arterial tree, and it is deadly for one reason: the right ventricle cannot pump against an abruptly obstructed outflow. The clinical pathway is built from a pre-test probability, a test whose value depends entirely on that probability, and a risk stratification that decides whether the patient needs anticoagulation, monitoring, or thrombolysis. Pulmonary hypertension is the chronic consequence of an obstructed, constricted or overloaded pulmonary circulation, and its management begins with the group the disease belongs to.
Next module: gastroenterology and hepatology. Method 5: endocrinology and metabolism, in which the endocrine assessment is followed by diabetes mellitus, adrenal and pituitary disease, and the metabolic emergencies.